Abstract
Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From 2 Phase 3, Randomized, Double-blind Studies
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have